This report contains market size and forecasts of Glucocorticoid for Systemic Lupus Erythematosus in Global, including the following market information:
Global Glucocorticoid for Systemic Lupus Erythematosus Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glucocorticoid for Systemic Lupus Erythematosus market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hydrocortisone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucocorticoid for Systemic Lupus Erythematosus include Pfizer, Sanofi, Teva, Akorn, GSK, Bausch and Lomb, Bayer Pharmas, Fougera Pharms and Hikma Intl Pharms, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucocorticoid for Systemic Lupus Erythematosus companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucocorticoid for Systemic Lupus Erythematosus Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Glucocorticoid for Systemic Lupus Erythematosus Market Segment Percentages, by Type, 2021 (%)
Hydrocortisone
Prednison
Prednisolone
Triamcinolone Acetonide
Dexamethasone
Betamethasone
Other
Global Glucocorticoid for Systemic Lupus Erythematosus Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Glucocorticoid for Systemic Lupus Erythematosus Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Other
Global Glucocorticoid for Systemic Lupus Erythematosus Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Glucocorticoid for Systemic Lupus Erythematosus Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glucocorticoid for Systemic Lupus Erythematosus revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glucocorticoid for Systemic Lupus Erythematosus revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Teva
Akorn
GSK
Bausch and Lomb
Bayer Pharmas
Fougera Pharms
Hikma Intl Pharms
Impax Labs
Lannett
Merck
Novartis
Sandoz
TARO
Valeant
Wockhardt
Solvay Pharma
Alcon
Paladin Labs
Adcock Ingram
ADARE Pharmaceuticals
Aspen Holdings
Astellas Pharma
Endo International
Sun Pharmaceutical
Perrigo
Aerosol